1-14 of 14
glucocorticoids
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells

Elina Parri, Heikki Kuusanmäki, Daria Bulanova, Satu Mustjoki, Krister Wennerberg
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1862–1875.
https://doi.org/10.1182/bloodadvances.2020003300
Published: 2021
Includes: Supplemental data
Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Clinical Trials & Observations
Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1352–1359.
https://doi.org/10.1182/bloodadvances.2020003937
Published: 2021
Includes: Supplemental data
Journal Articles

The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease

Clinical Trials & Observations
Robert Zeiser, Gérard Socié
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3789–3794.
https://doi.org/10.1182/bloodadvances.2020002097
Published: 2020
Journal Articles

Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells

Rafet Basar, May Daher, Nadima Uprety, Elif Gokdemir, Abdullah Alsuliman, Emily Ensley, Gonca Ozcan, Mayela Mendt, Mayra Hernandez Sanabria, Lucila Nassif Kerbauy, Ana Karen Nunez Cortes, Li Li, Pinaki P. Banerjee, Luis Muniz-Feliciano, Sunil Acharya, Natalie W. Fowlkes, Junjun Lu, Sufang Li, Stephan Mielke, Mecit Kaplan, Vandana Nandivada, Mustafa Bdaiwi, Alexander D. Kontoyiannis, Ye Li, Enli Liu, Sonny Ang, David Marin, Lorenzo Brunetti, Michael C. Gundry, Rolf Turk, Mollie S. Schubert, Garrett R. Rettig, Matthew S. McNeill, Gavin Kurgan, Mark A. Behlke, Richard Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3357–3367.
https://doi.org/10.1182/bloodadvances.2020001977
Published: 2020
Includes: Supplemental data
Journal Articles

ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia

Kayleigh M. Gallagher, Justine E. Roderick, Shi Hao Tan, Tze King Tan, Leonard Murphy, Jun Yu, Rui Li, Kevin W. O’Connor, Julie Zhu, Michael R. Green, Takaomi Sanda, Michelle A. Kelliher
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3154–3168.
https://doi.org/10.1182/bloodadvances.2020001555
Published: 2020
Includes: Supplemental data
Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Clinical Trials & Observations
Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1656–1669.
https://doi.org/10.1182/bloodadvances.2019001043
Published: 2020
Includes: Supplemental data
Journal Articles

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia

Hanny Al-Samkari, Rachel P. Rosovsky, Rebecca S. Karp Leaf, David B. Smith, Katayoon Goodarzi, Annemarie E. Fogerty, David B. Sykes, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 4 (1): 9–18.
https://doi.org/10.1182/bloodadvances.2019000868
Published: 2019
Includes: Supplemental data
Journal Articles

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold, George Buchanan, Douglas B. Cines, Nichola Cooper, Adam Cuker, Jenny M. Despotovic, James N. George, Rachael F. Grace, Thomas Kühne, David J. Kuter, Wendy Lim, Keith R. McCrae, Barbara Pruitt, Hayley Shimanek, Sara K. Vesely
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3829–3866.
https://doi.org/10.1182/bloodadvances.2019000966
Published: 2019
Includes: Supplemental data
Journal Articles

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W. G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3241–3247.
https://doi.org/10.1182/bloodadvances.2019000811
Published: 2019
Includes: Supplemental data
Journal Articles

Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD

Clinical Trials & Observations
Madan Jagasia, Christof Scheid, Gérard Socié, Francis Ayuketang Ayuk, Johanna Tischer, Michele L. Donato, Árpád Bátai, Heidi Chen, Sheau-Chiann Chen, Thomas Chin, Henri Boodée, Ghaith Mitri, Hildegard T. Greinix
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2218–2229.
https://doi.org/10.1182/bloodadvances.2019000145
Published: 2019
Includes: Supplemental data
Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Clinical Trials & Observations
Tania Jain, Mark R. Litzow
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3393–3403.
https://doi.org/10.1182/bloodadvances.2018020198
Published: 2018
Journal Articles

Complement-mediated thrombotic microangiopathy associated with lupus nephritis

Mi Hee Park, Nicholas Caselman, Scott Ulmer, Ilene Ceil Weitz
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2090–2094.
https://doi.org/10.1182/bloodadvances.2018019596
Published: 2018
Journal Articles

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Clinical Trials & Observations
Shehzad Niazi, Ryan D. Frank, Mayank Sharma, Vivek Roy, Steve Ames, Teresa Rummans, Aaron Spaulding, Taimur Sher, Meghna Ailawadhi, Kirtipal Bhatia, Salman Ahmed, Winston Tan, Asher Chanan-Khan, Sikander Ailawadhi
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1120–1128.
https://doi.org/10.1182/bloodadvances.2018016717
Published: 2018
Includes: Supplemental data
Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2295–2301.
https://doi.org/10.1182/bloodadvances.2017009860
Published: 2017